archive,category,category-news,category-73,strata-core-1.1,strata-theme-ver-3.3,ajax_fade,page_not_loaded,mob-menu-slideout-over,wpb-js-composer js-comp-ver-6.4.1,vc_responsive


First Treatment for ASMD approved by FDA

14:07 04 September in News

The US FDA has announced approving Xenpozyme (Olipudase alfa), for intravenous infusion in pediatric and adult patients with Acid Sphingomyelinase Deficiency (ASMD). The medication is the first to treat symptoms that are not related to the central nervous system in patients with ASMD. ASMD is...

Pharmacovigilance Free Webinar

12:35 17 August in News

One of the most evolving fields nowadays is pharmacovigilance . Want to know more about it? Register now in our #freewebinar on August 24, 2022 at 12:00 p.m. Lebanon time.For #registration, click the link below.👉🏻 https://bit.ly/3SFDigh #phoenixclinicalresearch #webinar #pharmacovigilance ...